Skip to content

Alligator Bioscience

Search
- Se

Startpage
About Alligator
Research and development
Corporate governance
Investors
Business Development
Press releases
Contact
Events

Startpage
Calendar
Event

Alligator Bioscience AB reports financial results for the first 9 months of 2024 and for Q3 2024 and provides a business update Alligator Bioscience AB reports financial results for H1 2024 and Q2 2024 and provides a business update Bulletin from the annual general meeting in Alligator Bioscience AB on 7 May 2024 Alligator Bioscience AB reports financial results for Q1 2024 and provides a business update Alligator Bioscience publishes Annual Report for 2023

This event has passed.

21 October, 2021

Interim report July – September 2021

« SITC (Society for Immunotherapy of Cancer) 2019
Year-end report 2021 »

Google Calendar
iCalendar
Outlook 365
Outlook Live

Details

Date:: 21 October, 2021
Event Category:: Financial events

« SITC (Society for Immunotherapy of Cancer) 2019
Year-end report 2021 »

Updated 2022-11-10

Startpage
Calendar
Event

About Alligator

Alligator develops antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. The company is active in the early stages of drug development, from idea to clinical phase 2 studies and beyond.

Alligator Bioscience has global headquarters in Lund, Sweden, and is listed on Nasdaq Stockholm (ticker: ATORX).

Links

About Alligator
R&D
Corporate governance
Investors
News
Business Development
Privacy Policy
Glossary

Contact us

Headquarter
Alligator Bioscience AB
Medicon Village
Scheelevägen 2
SE-223 81 Lund Sweden

Phone:
+ 46 (0)46 540 82 00

info@alligatorbioscience.com
ir@alligatorbioscience.com
bd@alligatorbioscience.com

Follow us

Email subscription

Subscribe to get our pressreleases and investor alerts by email from Alligator Bioscience.

© Copyright 2024 – Alligator Bioscience AB
Privacy Policy | Use of Cookies | Change your cookie settings here.
Disclaimer Market data could be delayed. Delivered by Modular Finance.

Cookies

We use cookies for administering, monitoring and optimizing the website, and for analytical purposes, in accordance with what is stated in our cookie policy.

Settings Accept all

Cookies

Do your settings below. Or read our cookie policy.

Necessary
These cookies are not optional. They are needed for the website to function.
Statistics
In order for us to improve the website's functionality and structure, based on how the website is used.
Experience
In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
Marketing
By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.

Save Accept all